关键词: immunotherapy metastatic non-small cell lung cancer (NSCLC) neoantigens programmed-death 1 (PD-1) programmed-death ligand 1 (PD-L1) tumor heterogeneity tumor microenvironment tumor mutation burden
来 源:
DOI:10.3389/fonc.2020.569202
PDF(Sci-hub)
PDF(Pubmed)